|
Market Closed -
Nasdaq
16:00:00 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 556.75 USD | +1.66% |
|
+1.73% | +22.81% |
| Market Cap | 141B 122B 115B 104B 195B 13,330B 197B 1,358B 527B 6,815B 530B 518B 22,388B | P/E 2026 * |
32.8x | P/E 2027 * | 26.9x |
|---|---|---|---|---|---|
| Enterprise Value | 130B 113B 106B 96.61B 181B 12,326B 182B 1,255B 487B 6,302B 490B 479B 20,701B | EV / Sales 2026 * |
9.89x | EV / Sales 2027 * | 8.58x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Vertex Pharmaceuticals Incorporated
| 1 day | +1.66% | ||
| 1 week | +1.73% | ||
| Current month | +2.25% | ||
| 1 month | +16.69% | ||
| 3 months | +30.97% | ||
| 6 months | +14.55% | ||
| Current year | +22.81% |
| 1 week | 532.23 |  | 558.36 |
| 1 month | 465.51 | | 558.36 |
| Current year | 412.27 | | 558.36 |
| 1 year | 374.17 | | 558.36 |
| 3 years | 340.83 | | 558.36 |
| 5 years | 176.36 | | 558.36 |
| 10 years | 71.46 | | 558.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 2019-04-09 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/28/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 8/27/26 | Don | Director | -6,000 | 0.0024% | ||
| 7/21/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.66% | +1.73% | +38.84% | +58.57% | 141B | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 663B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 462B | |
| +1.26% | -2.80% | +31.28% | +37.32% | 344B | |
| +0.08% | +5.63% | +27.73% | +47.88% | 307B | |
| +1.07% | +0.06% | -0.73% | +13.38% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 239B | |
| +1.39% | +3.61% | -16.11% | -53.33% | 207B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.85% | -0.45% | +30.39% | +52.78% | 383.45B | |
| Weighted average by Cap. | +0.72% | -0.74% | +38.37% | +67.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.19B 11.38B 10.72B 9.77B 18.26B 1,246B 18.4B 127B 49.26B 637B 49.54B 48.46B 2,093B | 14.61B 12.6B 11.87B 10.82B 20.22B 1,380B 20.37B 141B 54.55B 706B 54.86B 53.66B 2,318B |
| Net income | 4.31B 3.71B 3.5B 3.19B 5.96B 407B 6B 41.43B 16.08B 208B 16.17B 15.81B 683B | 5.23B 4.51B 4.25B 3.87B 7.24B 494B 7.29B 50.3B 19.52B 252B 19.63B 19.2B 829B |
| Net Debt | -10.63B -9.17B -8.64B -7.87B -14.72B -1,005B -14.83B -102B -39.71B -514B -39.93B -39.06B -1,687B | -15.79B -13.62B -12.83B -11.69B -21.85B -1,491B -22.01B -152B -58.95B -762B -59.28B -57.98B -2,505B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | US$556.75 | +1.66% | 1,734,757 |
| 26-09-01 | US$547.65 | +0.57% | 735,119 |
| 26-08-31 | US$544.52 | +0.52% | 1,198,447 |
| 26-08-28 | US$541.69 | -1.07% | 886,917 |
| 26-08-27 | US$547.55 | +0.05% | 844,619 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
